CLAHRC North Thames PhD Marissa Mes enjoyed success at the prestigious Annual Scientific Meeting (ASM) of the Asthma UK Centre for Applied Research (AUK CAR).
Marissa won best poster presentation when she showcased her work to delegates during the conference (below) – her research focus is assessing whether pharmacists are a suitable delivery channel for an intervention aimed at asthma patients to improve their adherence to preventer inhalers.
Our congratulations to Marissa on her prize.
Marissa’s fellow CLAHRC PhD Caroline Katzer, who is developing and evaluating an intervention to improve adherence to inhaled corticosteroids (ICS) in adult asthma patients also showcased her work at the conference via both a poster and an oral presentation, which generated a lot of discussion, and was among those complimented on the quality of her presentations.
Both PhDs are funded by the CLAHRC and affiliated to AUKCAR.
The end of any year sees a number of “best of” charts published and research is no exception!
We’re delighted to report that a paper produced by the CLAHRC’s Dr Werner Leber and Professor Chris Griffiths and others is 2017’s most downloaded in The Lancet HIV. Dr Werner ‘s groundbreaking work represents the first time a model to explore the cost effectiveness of screening for HIV in primary care has been applied to the UK.
The work generated great media interest (below) and offers a model to measure cost-effectiveness for commissioners and providers of HIV care.
Read the paper:
Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis
Baggaley, Rebecca F et al.
The Lancet HIV , Volume 4 , Issue 10 , e465 – e474
Read the most downloaded list
Read a BITE sized summary of Werner’s work.
CLAHRC behaviour change researchers and PhDs Caroline Katzer and Marissa Mes were a big hit at the recent in ESPACOMP conference in Budapest Hungary. Caroline and Marissa presented to an audience of clinicians and allied health professionals interested in adherence
ESPACOMP (European Society for Patient Adherence, COMpliance and Persistence) promotes science concerned with the assessment of what patients do with medicines they have been prescribed – and the implications when they adhere, or don’t adhere to them. Their 2017 conference brought together behaviour change practitioners and researchers from across the world and both Marissa and Caroline’s presentation generated much interest and a host of questions from the audience.
Both Caroline and Marissa are conducting their PhDs as as part of our wider work examining the effectiveness of the ‘Perceptions and Practicalities Intervention’ (PAPI) in improving adherence to asthma medication.
Marissa (above) is investigating the effectiveness of pharmacists as the delivery channel of a theory-based intervention to support medication adherence in adults with asthma.
Caroline is focusing her PhD on developing the PAPI intervention to support adherence to maintenance treatment in adult asthma patients.
Both fielded questions from pharmacists interested in how their research/academic findings were going to be translated into pharmacy practice, and how feasible this would be.
Decision-makers in public health can be confronted with a huge volume of data, evidence, reviews and summaries – from local and national sources. There is also an acknowledged gap between evidence and policy in public health.
In a recent blog on the EPPI centre website CLAHRC researchers Dylan Kneale and Antonio Rojas-García reflect on their work exploring the use of evidence in local public health decision-making – and raise the question – How much research is being wasted because it is not generalisable in local settings?
While reduced resources make judicious use of evidence more important than ever when deciding how and where to apply resources, researchers also need to understand, and better communicate, the generalisability of their research evidence to decision-makers working locally.
We have been reaching out to colleagues in local authorities and public health departments to highlight the value of research evidence in improving health and well being among local populations. The CLAHRC is forging useful links with our partners in local councils, bridging the gap between research and the front line.
Local authorities are a key audience for the CLAHRC as they are responsible for public health in their area. Public health includes prevention of illness and disease, sexual health and smoking cessation.
CLAHRC partners Islington and Camden Councils run lunchtime learning sessions for staff as part of their Using Data Better initiative. They invite speakers from various sectors to present the potential for data to improve health and health services for local residents. The boroughs have joined forces to deliver public health, and have a team of data analysts at work – identifying issues that have a negative effect on people’s health, and planning to deal with those issues.
In October Dr Chiara De Poli (below left) presented to public health staff and analysts in the two Councils. Chiara was joined by the CLAHRC’s Professor Gwyn Bevan and health economist Dr Elena Pizzo, presenting evidence of the limited impact of current policy options on the projected diabetes ‘epidemic’ in Islington, which stimulated a lively discussion about what Islington might do to tackle this.
Chiara’s work is part of a wider CLAHRC study, led by Professor Bevan, investigating the design of research and decision support processes to ensure the utility of research outputs. We are making efforts to make our research more “user friendly” and accessible to colleagues in the NHS and local government so they can use it in decision-making around planning and commissioning services and interventions for the populations they serve.
There was learning on both sides – our researchers got an insight into the challenges faced by staff on the front line and an appreciation of the type of data local authorities collect and analyse to improve health and well-being. We offered projections on the likely impact on diabetes prevention of current policies adopted by local authorities.
Feedback from our audience was extremely positive and we hope this is the start of a fruitful collaboration between the CLAHRC and the Public health teams within Islington and Camden.
“Once again, thanks for delivering a wonderful presentation – many of us were fascinated by your progress, and it’s no surprise that our head of dept. is now keen to collaborate further”
Mustafa Kamara, Intelligence & Information Analyst, Camden and Islington Public Health
CLAHRC researcher Dr Lorelei Jones has been invited to deliver a seminar on the role of clinical leaders on NHS boards in quality improvement (QI).
The Health Services Research Centre is a leading authority on health care management and has invited Lorelei as part of their prestigious events series.
The poster below gives an overview of what she will be covering.
Dr Jones is part of our iQUASER study looking at how NHS boards implement QUASER – a dialogical tool for senior hospital leaders to develop and implement QI strategies across their organisation.
Lorelei will be presenting some results from her extensive fieldwork among NHS boards for this research, which involved interviewing board members, observing meetings and scrutinising papers and documents.